Zhejiang Chyszern Technology Co., Ltd

Country/Region: China     State/Province: Beijing

Main Products: Amprolium, Amprolium

Company Introduction
In the most revolutionizing industry ZHEJIANG CHYSZERN TECHNOLOGY CO., LTD Private Limited has reached a milestone owing to the top notch production facility with technologically advanced equipment to manufacture first in class Amprolium, committing reliability, durability and optimum functioning. Since our inception, back in 2011 we have designed products to provide electrical solution having no match because we only source raw material that caters to durability, safety and meets international standards. Our export operations invaded international market as well, now holding Australia,Canada,South Korea,Nigeria,United Kingdom export market share with gross export ratio value of Above US$100 Million. Products we count on include Amprolium, helping us generate overall annual revenue across Approx More Than 1 Billion US Dollar. Electronic products in the market never go out of demand and to successfully meet that, our production potential is always on point, thanks to our manufacturing facility with Own Lisence, situated in BEIJING, , China.As a leading Manufacturer and Exporter, we hold export history of 9 Years , covering a milestone from where we began first with initial business capital of US$1 Million - US$2.5 Million.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2011, 2011

Legal Status: Own Lisence

Ownership: Private Limited

Employees: Above 1000 People

Factory Size: 50, 000-100, 000 square meters

R&D Team Size: Fewer than 5

Certifications: FSC

Contact Information

Contact Person: qian

Designation: Administrative

Department: Buyer

Telephone: 868657156030768

Business Information

Main Markets: Australia (29%) Canada (27%) Nigeria (23%) United Kingdom (21%) South Korea (16%)

Export Focus: Australia, Canada, South Korea, Nigeria, United Kingdom

Contract Services: Buyer Label Offered

Trade & Financial Information

Annual Revenue: Approx More Than 1 Billion US Dollar

Registered Capital: US$1 Million - US$2.5 Million

Export Percentage: 41% - 50%

Payment Terms: Bank wire (T/T)

Product Showcase
Amprolium
Amprolium

CL-Link > Health & Medicines in China Health & Medicines in Beijing Health Care Supplement in China Health Care Supplement in Beijing